Stockscreener 앱 받기
112.03
0.83%
0.92
시간 외 거래:
112.03
전일 마감가:
$111.11
열려 있는:
$111.11
하루 거래량:
1.10M
Relative Volume:
1.44
시가총액:
$13.63B
수익:
$2.72B
순이익/손실:
$254.30M
주가수익비율:
18.84
EPS:
5.9463
순현금흐름:
$564.37M
1주 성능:
+2.29%
1개월 성능:
-5.68%
6개월 성능:
-0.57%
1년 성능:
+25.20%
1일 변동 폭
$109.17
$112.63
1주일 범위
$107.17
$114.13
52주 변동 폭
$86.30
$129.50
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
RVTY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| RVTY | 112.03 | 13.63B | 2.72B | 254.30M | 564.37M | 5.9463 |
| TMO | 513.26 | 196.32B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 235.84 | 170.34B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 133.84 | 38.48B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 201.82 | 36.63B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 417.24 | 34.17B | 3.84B | 866.24M | 792.60M | 9.80 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
Wells Fargo Initiates Coverage of Revvity (RVTY) with Equal-Weight Recommendation - MSN
Revvity, Inc. (NYSE:RVTY) Shares Sold by Primecap Management Co. CA - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity Partners with Genomics England to Screen 100,000 Newborns for Rare Conditions | RVTY Stock News - StockTitan
Revvity CEO to Present Strategic Update at Evercore ISI HealthCONx Conference | PKI Stock News - StockTitan
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells - BioSpace
Revvity CEO to Present Strategic Update at Evercore ISI HealthCONx Conference | RVTY Stock News - StockTitan
Revvity updates organizational structure - Nasdaq
Revvity Announces Major Restructuring, Sets 2024 Investor Day for Strategic Update | RVTY Stock News - StockTitan
Sumitomo Mitsui Trust Group Inc. Purchases 9,473 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Impax Asset Management Group plc Sells 10,233 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Select Equity Group, L.P. Reduces Stake in Revvity Inc - GuruFocus.com
RSI Alert: Revvity (RVTY) Now Oversold - Nasdaq
T. Rowe Price Investment Management, Inc. Reduces Stake in Revvi - GuruFocus.com
Janus Henderson Group PLC's Strategic Acquisition of Shares in R - GuruFocus.com
Sivik Global Healthcare LLC Purchases New Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Bretton Capital Management LLC Invests $1.41 Million in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative - Simply Wall St
Capital Research Global Investors Bolsters Position in Revvity I - GuruFocus.com
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
These Analysts Revise Their Forecasts On Revvity Following Q3 Results - MSN
FY2024 EPS Estimates for Revvity Boosted by Leerink Partnrs - MarketBeat
Revvity stock price target lifted, outperform rating on strong results By Investing.com - Investing.com Canada
Revvity Inc. stock rises Tuesday, still underperforms market - MarketWatch
TD Cowen Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Raymond James Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
TD Cowen increases Revvity stock price target, keeps buy on stable signs - Investing.com Canada
Revvity Announces Financial Results for the Third Quarter of 2024 - BioSpace
Revvity, Inc. (NYSE:RVTY) Q3 2024 Earnings Call Transcript - Insider Monkey
Revvity stock price target lifted, outperform rating on strong results - Investing.com India
Revvity beats Q3 expectations, raises full-year EPS outlook - Investing.com India
Revvity Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges - GuruFocus.com
KeyBanc maintains $132 target on Revvity amid EPS guidance raise By Investing.com - Investing.com Canada
Revvity Inc price target raised to $134 by Evercore ISI - Investing.com Canada
Q3 2024 Revvity Inc Earnings Call - Mujer es Más
Revvity Reports Strong Q3 Growth and New Share Buyback - TipRanks
Revvity Adjusts Revenue Forecast But Lifts Profit Expectations - Finimize
Earnings call: Revitty reports solid Q3 with $684 million in revenue - Investing.com
Revvity (NYSE:RVTY) Hits New 52-Week HighWhat's Next? - MarketBeat
KeyBanc maintains $132 target on Revvity amid EPS guidance raise - Investing.com
RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised - MSN
Revvity Inc (RVTY) Shares Up 5.6% on Nov 4 - GuruFocus.com
Developing image-based T-cell assays for monitoring apoptosis and CAR expression - News-Medical.Net
Revvity climbs after raising 2024 profit forecast - XM
Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings - Yahoo Finance
Revvity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2024 - Marketscreener.com
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
1.35%
자본화:
|
볼륨(24시간):